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Background
Repetitive TMS (rTMS) is effective in migraine
prophylaxis.
Introduction
To study the efficacy of high-frequency rTMS in medi-
cation overuse headache (MOH).
Methods
A prospective, double-blind, randomized, placebo-con-
trolled trial on patients suffering from MOH consecutively
presenting in a six-month period in the Headache Centre of
Trieste was performed. Patients were randomized into the
rTMS or the sham-TMS group. Treatment consisted of 10
consecutively TMS sessions delivered on left dorsolateral
prefrontal cortex, each session being 10 trains of 2-s dura-
tion, separated by 30-s pause, 20 Hz frequency, 100% motor
threshold intensity. Demographic and clinical information,
MIDAS score, headache days (HD), hours of headache
(HH), and symptomatic drugs (SD) in the 3 months before
(t1), and in the first (t2) and second month (t3) after stimu-
lation were analysed using SPSS 14.0.
Results
We enrolled 8 patients (7 F, 1 M; mean age 44 ± 11), four
patients undewent rTMS and four sham-TMS. All patients
were migraineurs without aura as initial primary headache.
We found, in both rTMS and sham-TMS group, no signifi-
cant difference between the 3 months before and the
2 months after stimulation (rTMS: HD= 22 ± 6 t1 vs 22 ±
11 t2 vs 19 ± 14 t3, HH= 223 ± 205 t1 vs 219 ± 198 t2 vs
205 ± 196 t3, SD= 22 ± 10 t1 vs 18 ± 7 t2 vs 16 ± 8 t3;
sham-TMS: HD= 22 ± 5 t1 vs 12 ± 6 t2 vs 13 ± 8 t3, HH=
180 ± 117 t1 vs 99 ± 73 t2 vs 97 ± 28 t3, SD= 22 ± 10 t1 vs
16 ± 3 t2 vs 17 ± 4 t3). MIDAS score significantly reduced
in rTMS group at a three-month evaluation (111 ± 29 vs 42
± 27; p=0.03).
Conclusions
Our preliminary data suggest that high-frequency rTMS
is not useful to treat MOH, however the small sample
does not allow to draw safe conclusions.
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